Opalite Health

Cover Block

Company	Opalite Health
Tagline	AI speech-to-speech medical interpreter for 150+ languages with EHR integration
Headquarters	San Francisco, United States
Founded	2025
Stage	Seed
Business Model	B2B
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Undisclosed

Links

• Website: https://opalitehealth.com/
• LinkedIn: https://www.linkedin.com/company/opalite-health

What an Investor Needs First

Opalite Health is a Y Combinator-backed startup applying real-time AI speech-to-speech interpretation to a persistent and costly problem in healthcare: the language barrier between clinicians and patients. The company's early momentum, driven by a physician-founder with a personal connection to the problem, merits investor attention for its potential to automate a critical, non-discretionary service line within provider budgets.

The company was founded in 2025 by Cathleen Kuo, a physician and AI researcher, after she witnessed her immigrant parents struggle within the U.S. healthcare system [Y Combinator LinkedIn, 2026]. Its core product translates clinician-patient conversations across 150+ languages directly within clinical workflows, integrating with electronic health records and generating automated documentation [Opalite Health, 2026]. The primary wedge is economic, claiming to replace traditional interpreter services with software that is "over 50% cheaper" while being faster and embedded in the care experience [Y Combinator LinkedIn, 2026].

Cathleen Kuo brings a relevant background in AI healthcare research, with a reported 150+ publications and prior experience as a co-founder of MedDx, an AI prognostic platform [F6S, 2026]. Technical leadership is provided by co-founder and CTO Alex Mehregan [Crunchbase, 2026]. The company is currently in the seed stage, having completed the Y Combinator Winter 2026 batch, but the specific amount of capital raised and any other investors remain undisclosed [F6S, 2026].

Over the next 12-18 months, the key watchpoints will be the validation of its quality and cost claims at scale, the signing of named enterprise health system customers, and the expansion of its team to support a complex enterprise sales and implementation motion. Early, unverified traction signals include translating over 10,000 minutes per month across more than 10 U.S. states [Y Combinator LinkedIn, 2026] [Hiretop, 2026].

Data Accuracy: YELLOW -- Core product claims are confirmed by the company website. Foundational team and traction details are sourced from secondary platforms (F6S, Hiretop) and a Y Combinator post, but lack independent verification from major news outlets.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

Inside the Company

Opalite Health was founded in 2025 by CEO Cathleen Kuo and CTO Alex Mehregan, emerging from Kuo's personal experience watching her immigrant parents navigate the U.S. healthcare system with a language barrier [Y Combinator, 2026]. The company is headquartered in San Francisco, California [F6S, 2026] [Hiretop, 2026].

Key milestones follow a compressed timeline typical of Y Combinator-backed ventures. The company was accepted into the Y Combinator Winter 2026 batch [F6S, 2026]. Shortly after, Opalite began deploying its product, with the company claiming it is "already live across hospitals and clinics, translating 10,000+ minutes per month" and in active use across more than ten U.S. states by 2026 [Y Combinator, 2026] [Hiretop, 2026].

Data Accuracy: YELLOW -- Founding story and YC affiliation confirmed by Y Combinator; headquarters and early traction claims are single-source or partially corroborated.

Under the Hood

The core proposition is an AI interpreter that sits directly inside a clinical workflow, aiming to replace scheduled human services with on-demand software. According to the company's website, the product delivers real-time, speech-to-speech interpretation across more than 150 languages, integrated with electronic health record systems and built on a HIPAA-compliant infrastructure [Opalite Health, 2026].

Beyond translation, the system generates automated clinical documentation from the interpreted conversation [Extruct AI, 2026]. The company claims its software is "over 50% cheaper" than traditional interpretation services [Y Combinator, 2026]. Public traction claims, such as translating over 10,000 minutes per month across hospitals and clinics, suggest the product is beyond a prototype and in active, albeit early, deployment [Y Combinator, 2026].

Data Accuracy: YELLOW -- Core product claims are sourced from the company website and Y Combinator; traction and documentation features are reported by secondary profiles.

Market Research

The market for language services in U.S. healthcare is a persistent, multi-billion dollar operational cost center. According to a 2022 report from Grand View Research, the global healthcare interpreting services market was valued at $5.6 billion and was projected to grow at a compound annual rate of 5.5% through 2030 [Grand View Research, 2022]. The U.S. represents the largest regional segment of this market, driven by federal mandates including Title VI of the Civil Rights Act and Section 1557 of the Affordable Care Act [Hiretop, 2026].

Metric	Value
Global Healthcare Interpreting Services (2022)	$5.6B
Projected Annual Growth Rate (2022-2030)	5.5%

Data Accuracy: YELLOW -- Market sizing is from an analogous, dated third-party report; demand driver and regulatory context are cited from secondary analysis.

Competition and Substitutes

Opalite Health enters a fragmented market for language services in healthcare, positioned as a software-first challenger to traditional human interpreter networks and emerging AI point solutions.

The competitive map splits into three distinct segments. The incumbent layer consists of large, established human interpretation services like LanguageLine Solutions and AMN Healthcare's Stratus Video. The second segment includes AI-native challengers. The third comprises adjacent substitutes: telehealth platforms with built-in interpretation and EHR vendors.

Opalite's current edge appears to rest on two pillars: workflow integration and founder credibility. The company's emphasis on deep "EHR integration" and "automated clinical documentation" aims to embed the tool directly into clinician workflows [Extruct AI, 2026] [Opalite Health website, 2026]. CEO Cathleen Kuo's background as a physician and AI researcher provides a credential that may accelerate trust-building [F6S, 2026].

Data Accuracy: YELLOW -- Competitive analysis is inferred from market structure; no named competitors are confirmed in public sources. Opalite's positioning claims are sourced from its website and Y Combinator materials.

Opportunity

If Opalite Health can successfully replace the traditional medical interpreter services market with its AI-driven software, the financial and operational prize is measured in billions of dollars of annual spend currently locked in a fragmented, high-latency, and labor-intensive industry.

Scenario	What happens	Catalyst	Why it's plausible
Enterprise Standardization	A major national health system or payer selects Opalite as its preferred vendor.	A successful pilot within the "large healthcare enterprise" leads to a system-wide contract.	The product's design for EHR integration aligns with enterprise procurement criteria.
Telehealth Platform Partnership	Opalite becomes the white-labeled interpretation layer for a leading telehealth provider.	A partnership with a telehealth platform seeking to reduce interpreter costs.	The company's focus includes "telehealth services" as a core buyer.
Regulatory Mandate Expansion	New state or federal regulations create a compliance-driven adoption tailwind.	Legislation akin to updates to Section 1557 of the Affordable Care Act.	The company's early emphasis on HIPAA compliance positions it as a tool for demonstrating regulatory adherence.

Data Accuracy: YELLOW -- Growth scenarios are extrapolated from cited product claims and early traction reports; specific catalysts are referenced but not independently verified.

Sources

1. [Y Combinator, 2026] Opalite Health: Helping Healthcare Providers Speak Any Language | https://www.ycombinator.com/companies/opalite-health
2. [Opalite Health, 2026] Opalite Health | AI-Powered Medical Interpreter for Healthcare | https://opalitehealth.com/
3. [F6S, 2026] Opalite Health | https://www.f6s.com/company/opalite-health
4. [Hiretop, 2026] Opalite Health: Breaking Language Barriers in Healthcare | https://hiretop.com/blog5/opalite-health-language-barriers-healthcare/
5. [Extruct AI, 2026] Opalite Health Funding | Complete Analysis | Extruct AI | https://www.extruct.ai/hub/opalitehealth-com/
6. [Crunchbase, 2026] Alex Mehregan - Crunchbase Person Profile | https://www.crunchbase.com/person/alex-mehregan-41c4
7. [Grand View Research, 2022] Healthcare Interpreting Services Market Size Report, 2022-2030 | https://www.grandviewresearch.com/industry-analysis/healthcare-interpreting-services-market-report
8. [Y Combinator LinkedIn, 2026] Opalite Health (YC W26) is an AI medical interpreter | https://www.linkedin.com/posts/y-combinator_opalite-health-yc-w26-is-an-ai-medical-activity-7420208655117221888-YNEf